Risk factors for tuberculosis in patients receiving tumour necrosis factor-α blockers: what do we really know?
Division of Infectious Diseases, Department of Medicine, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.
Philip R
PR
Botha
Coenraad F N
CF
Koegelenberg
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001528:Behcet Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014376:Tuberculosis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D014409:Tumor Necrosis Factor-alpha